School of Medicine
Showing 901-1,000 of 1,621 Results
-
Esmeralda Melgoza
Postdoctoral Scholar, Emergency Medicine
BioEsmeralda Melgoza, PhD, MPH, CHES is a postdoctoral researcher in the Department of Emergency Medicine at Stanford University's School of Medicine. Her research examines health inequities in the U.S. healthcare system, with a focus on emergency medical services provided in the prehospital setting and the emergency department. She centers her research on the experiences of underserved populations, including Latine/Hispanics, older adults, and people with limited English proficiency. She is trained in both quantitative and qualitative methods. Her research has been published in peer-reviewed journals, including JAMA Network Open, Medical Care, the Journal of the American Heart Association, Health Affairs Scholar, Prehospital Emergency Care, and SSM-Qualitative Research in Health, among others.
Dr. Melgoza received her PhD in Community Health Sciences from the UCLA Fielding School of Public Health and a minor in Gerontology from the USC Leonard Davis School of Gerontology. Her dissertation research was funded by an R36 grant from the National Institute on Aging. Dr. Melgoza is a former Senior Research Analyst at the UCLA Latino Policy and Politics Institute and an alumna of the Yale Ciencia Academy at Yale University. She is bilingual in English and Spanish. In her spare time, she enjoys spending time with her family, traveling, mentoring, and hiking. -
Yan Mia Min
Postdoctoral Scholar, Cardiothoracic Surgery
BioYan Mia Min is currently a Ph.D. candidate in Epidemiology and Population Health and a Stanford Data Science Scholar. Her background is in medicine and health economics. She completed her residency in general surgery. She just completed her Master's in Statistics in the summer of 2022.
Yan has worked as a health policy analyst in the health finance cluster at the World Health Organization in Geneva. She also took a leadership role in establishing the WELL Living Laboratory Cohort at the Stanford Prevention Research Center.
Yan’s current research is focused on rigorous causal inference theories and modeling in large-scale observational settings, with particular applications in cardiothoracic surgeries, where randomization is often unavailable. Her training in epidemiology makes her share a strong sense of integrity in research conduct. Along with her teammates, Yan is writing an e-book, Open, Rigorous and Reproducible Science: A Practitioner’s Manual, to address the following three phases of scientific research: design, analysis, and publication. -
Pardis Miri
Basic Life Research Scientist, Genetics
BioPardis Miri, PhD, is a Research Scientist and former Postdoctoral Fellow at Stanford University, where she develops technology aimed at improving mental well-being. She holds a PhD in Computer Science and has extensive training in affective science under Professor James J. Gross. Pardis leads a multidisciplinary team (http://wehab.stanford.edu
) conducting clinical and real-world studies to assess how wearable technologies can reduce stress and enhance glymphatic flow in early-stage Alzheimer’s patients.
During her postdoctoral work, Pardis served as the principal investigator of FAR, a multi-disciplinary project to design, build, and evaluate an end-to-end wearable system for children with emotion dysregulation, including those diagnosed with autism spectrum disorder. FAR aims to support more adaptive emotion-regulation strategies through a combination of systems design and behavioral research.
Pardis is advised by Professors Michael Snyder, Keith Marzullo, and James J. Gross, and collaborates with Professor Antonio Hardan of the Stanford School of Medicine on research involving children with autism spectrum disorder. -
Vaishali Mittal
Member, Maternal & Child Health Research Institute (MCHRI)
BioVaishali Mittal, MD is a Postdoctoral Clinical Fellow in the Department of Dermatology at Stanford University under the guidance of Dr. Jean Y. Tang.
Her current research is focused on epidermolysis bullosa (EB), a group of rare diseases that cause the skin and mucous membranes to blister easily. She is involved in conducting long-term clinical trials examining the application of an autologous, gene-corrected keratinocyte sheet for the treatment of recessive dystrophic EB (RDEB). In addition, she is currently leading several research projects, including investigation of genotype-phenotype associations in multiple subtypes of EB, creation of an online platform for EB patients/families and investigators to collaborate together on research, and development of an online genetic registry for EB patients using a novel, home-based genetic testing kit.
Vaishali received her medical degree from Stanford University School of Medicine and completed her internship at Beth Israel Deaconess Medical Center/Brockton Hospital. -
Masashi Miyauchi
Basic Life Research Scientist, Medicine - Med/Hematology
BioMasashi Miyauchi, MD, PhD, is a physician-scientist specializing in hematology, oncology, immunology, and stem cell biology, with over a decade of experience in clinical hematology and oncology. Dr. Miyauchi's academic career commenced at Kyoto University, where he obtained his MD in Medicine. He furthered his expertise with a PhD in Internal Medicine from The University of Tokyo, Graduate School of Medicine. Following his comprehensive clinical training and professional appointments at The University of Tokyo Hospital, Dr. Miyauchi embarked on a postdoctoral journey at Stanford University in the Nakauchi lab, starting in July 2019.
Dr. Miyauchi's clinical training is extensive, including a Senior Residency in Internal Medicine and a Clinical Fellowship in Hematology and Oncology at The University of Tokyo Hospital. This period was complemented by his participation in a Cancer Professional Training Plan. After completing his clinical fellowship, Dr. Miyauchi has served in various pivotal roles at The University of Tokyo Hospital and The University of Tokyo. His positions as a clinically-focused Project Assistant Professor and Assistant Professor in the Department of Hematology and Oncology have enabled him to contribute significantly to pioneering research and education for the next wave of medical professionals.
In his PhD research, Dr. Miyauchi specialized in the disease modeling of cancers and cancer stem cells, employing cancer patient-specific induced pluripotent stem cells (iPSCs). His work with iPSCs notably includes scalable ex vivo manufacturing of human neutrophils. In his postdoctoral research under the guidance of Dr. Hiromitsu Nakauchi in Genetics at Stanford, Dr. Miyauchi has been concentrating on developing a stable hematopoietic stem cell (HSC) expansion system in both mouse and human models. His research is focused on exploring the potential applications of this expansion system, underlining his commitment to advancing the fields of stem cell biology, regenerative medicine and oncology. -
Ai Mochida
Postdoctoral Scholar, Radiation Therapy
Current Research and Scholarly InterestsIn the Ross lab, I study hematopoietic stem cell biology in aging and cancer.
-
Islam Mohamed Nour Hassan Mohamed
Postdoctoral Scholar, Pediatric Surgery
BioDr. Islam Nour is a molecular virologist with over fifteen years of research experience spanning viral genomics, reverse genetics, and structural–functional analysis of pathogenic RNA viruses. As a previous postdoctoral fellow in Molecular Virology at USDA-ARS, he designed and deployed reverse-genetics systems for IBDV and avian reovirus, integrated Illumina and Oxford Nanopore sequencing with comparative genomics, and coupled these approaches to IHC/IF-based pathogenesis models. His earlier work on rotavirus and SARS-CoV spike evolution, protein modelling, and molecular viral surveillance further strengthened his ability to connect viral sequence variation to phenotypic outcomes and tissue injury. He is particularly motivated to bring this mechanistic and translational expertise to multidisciplinary clinical teams in pediatric liver disease and transplantation in division of pediatric surgery in Stanford Medicine, contributing rigorous viral pathogenesis, vector design, and protein expression skills to clinically relevant models and biomarker discovery.
-
Shadi Momtahen
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsI develop machine-learning models that combine clinical records, laboratory and immunogenetic data, and wearable physiological signals to support transfusion medicine and patient monitoring.
-
Samuel Montalvo
Postdoctoral Scholar, Cardiovascular Medicine
BioAs a clinical exercise physiologist and sport scientist, I study the mechanical, physiological, and molecular determinants of human performance and health. I am certified as a Performance and Sport Scientist (CPSS), Strength and Conditioning Specialist with Distinction (CSCS,*D), and Clinical Exercise Physiologist.
I am a Postdoctoral Scholar in Cardiovascular Medicine at Stanford University and a member of the Stanford Bioinformatics Center and Wu Tsai Human Performance Alliance. My training has been supported by the Wu Tsai Human Performance Alliance Postdoctoral Fellowship, the NIH T32 Research Training in Myocardial Biology at Stanford, and a two-year NIH/NHLBI Loan Repayment Program award in Research in Emerging Areas Critical to Human Health.
My research integrates clinical exercise physiology, cardiopulmonary exercise testing, biomechanics, and multi-omics to better understand how physical activity influences cardiovascular health, biological adaptation, and athletic performance. Through the NIH-funded Molecular Transducers of Physical Activity Consortium (MoTrPAC), I analyze large clinical, multi-omic, multi-tissue, multimodal, and multi-species datasets to identify mechanisms and biomarkers of exercise response.
I also collaborate on projects involving sports cardiology and electrocardiography, cardiopulmonary exercise testing, exercise and neuromuscular disease, and athlete performance, including work with Stanford Baseball and external sports-science collaborators.
I contribute to professional and institutional service as a Senior Editor for the Journal of Strength and Conditioning Research and Financial Officer of the Stanford University Postdoctoral Association (SURPAS).
Teaching and mentoring are central to my academic work. As a first-generation college graduate and Mexican American with Indigenous heritage, I am committed to creating supportive and inclusive pathways for trainees from underrepresented backgrounds. I serve as a Postdoctoral Mentoring Coach with the Stanford Office of Postdoctoral Affairs and mentor undergraduate, graduate, and medical trainees and residents through several Stanford programs and initiatives, including PRISM and the MAVERICs program within the Stanford Cardiovascular Institute.
My long-term goal is to lead an independent research program that combines exercise physiology, multi-omics, physical activity, nutrition, cardiovascular science, and sports performance while mentoring the next generation of scientists. -
Bryan Mosher, MD, PhD
Clinical Scholar, Medicine - Cardiovascular Medicine
Postdoctoral Scholar, Cardiovascular MedicineBioDr. Mosher is a dual-fellowship-trained cardiologist at Stanford Health Care. He is also aa clinical scholar and postdoctoral scholar in the Department of Medicine, Division of Cardiovascular Medicine at Stanford University School of Medicine.
Dr. Mosher specializes in adult congenital heart disease (heart problems present since birth), such as tetralogy of Fallot, Fontan physiology, and systemic right ventricular dysfunction. His training in general pediatrics, pediatric cardiology, and adult congenital heart disease gives him a deep understanding of how these conditions change throughout life. He takes a collaborative and proactive approach to care, emphasizing careful evaluation. He also focuses on strategies to prevent complications and support long-term cardiovascular health.
As a physician-scientist, Dr. Mosher studies how the heart adapts to congenital heart disease and prior surgery. He also investigates how heart function affects long-term health and the ability to exercise. His work combines detailed assessments of cardiovascular structure and function with emerging technologies and wearable monitoring devices. He also explores precision medicine approaches to understand individual differences in disease better and develop personalized approaches to care. As a member of the Stanford Maternal & Child Health Research Institute, he focuses on translating advances in cardiovascular research into improved care for people living with congenital heart disease.
Dr. Mosher has authored numerous peer-reviewed publications in science and medical journals. He has also presented his research at medical conferences around the world. His work has been featured at meetings of the World Congress of Pediatric Cardiology and Cardiac Surgery, the Society of Thoracic Surgeons, the Pediatric and Congenital Interventional Cardiovascular Society, the International Symposium on Adult Congenital Heart Disease, and the American Heart Association (AHA) Scientific Sessions.
Dr. Mosher is a member of the AHA, Adult Congenital Heart Association (ACHA), American College of Cardiology (ACC), American Academy of Pediatrics (AAP), and American College of Physicians (ACP). -
Sakib Mostafa
Postdoctoral Scholar, Radiation Physics
BioI am a Postdoctoral Research Fellow at Stanford University with a background in computational genomics and deep learning. My research focuses on developing AI-powered tools for genomic analysis, with a particular interest in cancer classification, pangenomes, and genotype imputation. Previously, I worked as a Research Officer at the National Research Council of Canada, contributing to large-scale sequencing projects and machine learning interfaces for biologists. I am passionate about bridging domain biology with cutting-edge computational methods to solve complex biological questions and drive innovation in precision agriculture and healthcare.
-
Eric Mou, MD
Postdoctoral Medical Fellow, Oncology
BioI was born in Oregon and raised in Iowa, where I cultivated my initial interest in science and medicine. I completed my undergraduate degree and medical school at the University of Iowa before heading to Stanford University for my internal medicine residency and oncology fellowship training. I chose this field to try my best in assisting patients during times of great need, and working to understand what is of greatest importance to them as they navigate their unique journey of cancer care. My clinical focus is in the care of patients with lymphoma and other hematologic cancers. My scholarly interests include better understanding the efficacy cancer therapeutics, improving patients' experience as the proceed through treatment, and promoting strength in medical education.
-
Salvinaz Islam Moutusy
Postdoctoral Scholar, Immunology and Rheumatology
BioI am a medical scientist with expertise in basic biomedical research focusing on Microbiology and Immunology. After getting medical license from Bangladesh, I received MD in Medical Microbiology from BSMMU, Bangladesh and MS in Environmental Health Science from the University of Tokyo School of Medicine, Japan.
-
Lucas Murray
Postdoctoral Scholar, Biochemistry
Current Research and Scholarly InterestsI use single-molecule tools and approaches to study the assembly and function of molecular machines. I currently am working to understand the interplay between genome structure and kinetochore assembly and function in vertebrates.
-
Adel Mutahar
Postdoctoral Scholar, General and Vascular Surgery
BioDr. Adel Z. I. Mutahar is a postdoctoral researcher in the Department of Surgery at Stanford University, working under the mentorship of Dr. Frederick M. Dirbas. His research focuses on translational breast cancer biology and emerging radiotherapy technologies, with an emphasis on tumor–microenvironment interactions, immuno-oncology, and preclinical therapeutic development. His academic journey spans three countries—beginning in Yemen, advancing through India, and now progressing at Stanford—reflecting his commitment to impactful cancer research and global scientific advancement.
Dr. Mutahar began his career in Yemen, earning his Bachelor’s degree in Medical Laboratory Sciences before joining Abs Community College as a faculty member. From 2007–2013, he held several academic leadership roles, including Academic Director, Head of Evaluation, and Assistant Dean of Students, where he modernized curriculum, expanded hands-on diagnostic training, and strengthened laboratory education infrastructure in resource-limited settings. His work contributed to building a more skilled medical diagnostics workforce and improving pathways for laboratory science education.
Awarded a prestigious national merit scholarship, Dr. Mutahar continued his graduate and doctoral training in India, completing his M.S. and Ph.D. in Biotechnology with a focus on triple-negative breast cancer. During his doctoral work, he developed 3D tumor spheroid models and combinatorial therapeutic strategies, demonstrating synergy between anti-angiogenic agents and chemotherapy in TNBC. He further advanced this research by creating an orthotopic murine model to investigate metastatic progression and demonstrated that knockdown of the MTA1 gene in mesenchymal stem cells (MSCs) significantly suppressed TNBC invasion, angiogenesis, and metastatic spread, introducing a promising stromal-targeted therapeutic concept for aggressive breast cancer. This work earned recognition through travel grants, conference presentations, and a Best Poster Award. His scientific adaptability was further demonstrated during the COVID-19 pandemic, when he uncovered a novel interaction between SARS-CoV-2 Spike RBD and VEGF signaling.
At Stanford, his work emphases on FLASH radiotherapy, an ultrahigh-dose-rate modality with the potential to widen the therapeutic window by minimizing normal-tissue toxicity while maintaining tumor control. Working within Dr. Dirbas’s translational breast oncology program, Dr. Mutahar employs patient-derived xenografts, orthotopic murine models, spatial transcriptomics, single-cell RNA sequencing, and immune profiling to dissect the biological mechanisms governing treatment response. His research integrates multi-omics analysis to map early and late radiotherapy injury pathways—including senescence, apoptosis and fibrosis. His goal is to develop mechanism-driven radio-immunotherapy strategies and durable FLASH-RT combination regimens that can be translated into clinical trials for breast cancer, improving therapeutic durability, minimizing toxicity, and ultimately enhancing patient outcomes.
Dr. Mutahar’s long-term vision is to establish an independent laboratory at the intersection of radiobiology, immuno-oncology, and translational therapeutics. Guided by Dr. Dirbas’s mentorship and shaped by multidisciplinary experience across three continents, he aims to develop biologically informed treatment strategies that eradicate tumors while preserving normal tissue and immune integrity—ultimately improving quality of life and survival for women with aggressive breast cancers. -
Dhriti Nagar
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioPremature birth is a leading cause of developmental and neuropsychiatric disorders in children. One of the factors causing these defects is lowered levels of available oxygen (hypoxia) in the newborn due to immature lungs. My research focuses on understanding the cellular and molecular mechanisms underlying hypoxia-induced developmental disorders of the nervous system due to preterm birth.
-
Michitaka Nakano
Basic Life Research Scientist, Medicine - Med/Hematology
BioI am a MD/PhD postdoctoral fellow and medical oncologist with a long-standing interest in translational cancer research. My long-term goal is to be a lab-based physician-scientist and independent academic researcher, translating basic cancer research, and mentoring next-generation scientists. My thesis work in Japan focused on cancer stem cell equilibrium by uniquely applying organoid culture as a method to elucidate cancer stem cell dynamics, which was awarded in Japanese Cancer Association. Along with the development of the field represented by success in T cell checkpoint, my interest gradually shifted to immune oncology while I examined numerous numbers of cancer patients as a medical oncology fellow. My postdoctoral fellowship at Calvin Kuo Lab in Stanford (2019-present) focuses on tumor immune microenvironment. Kuo lab developed a unique 3D air-liquid interface (ALI) organoid system that cultures tumors while preserving their endogenous infiltrating immune cells (T,B ,NK, Myeloid cells). My postdoctoral work will prove the significance of organoids as a translational tool to discover tumor-immune interaction by novel checkpoint inhibitors for immune cells, which can be broadly applicable to basic cancer biology, precision medicine, therapeutics validation and biomarker discovery.
-
Rohollah Nasiri
Postdoctoral Scholar, Radiation Physics
Current Research and Scholarly InterestsMy current research focuses on developing tumor-on-a-chip models for preclinical radiation therapy research.
-
Fateme (Fatima) Nateghi
Postdoctoral Scholar, Biomedical Informatics
BioAs a postdoc researcher at the Division of Computational Medicine, I find myself at the exciting intersection of machine learning and healthcare. My journey began with a PhD in Biomedical Sciences from KU Leuven in Belgium, where I explored the complexities of machine learning algorithms and their transformative potential in clinical settings. My research focused on adapting these algorithms for time-to-event data, a method used to predict when specific events may occur in a patient’s future.
At Stanford, my work centers on building trustworthy AI systems to enhance healthcare delivery. I develop and evaluate machine learning models that integrate structured electronic health records (EHRs) and unstructured clinical notes to support real-world clinical decision-making. My recent projects include predicting treatment retention in opioid use disorder, improving antibiotic stewardship for urinary tract infections, and enabling digital consultations through large language models (LLMs). I'm particularly interested in embedding-based retrieval and retrieval-augmented generation (RAG) methods that help bridge cutting-edge AI research with clinical practice.
My role involves not just advancing the integration of machine learning in healthcare but also collaborating with a diverse team of clinicians, data scientists, and engineers. Together, we're striving to unravel complex healthcare challenges and ultimately improve patient outcomes. -
Shaghayegh Navabpour
Postdoctoral Scholar, Psychiatry
Current Research and Scholarly InterestsMy research investigates how genetic, transcriptomic, and epigenomic mechanisms shape brain function and contribute to psychiatric disorders, with a special focus on PTSD. By combining large-scale human genomic data with molecular neuroscience approaches, I aim to identify cell-type-specific pathways and therapeutic targets that advance our understanding and treatment of mental health conditions.
-
Madelena Ng
Postdoctoral Scholar, Biomedical Ethics
BioDr. Madelena Ng is a Postdoctoral Scholar and NHGRI T32 ELSI Research Fellow at the Laurie J. Girand Center for Biomedical Ethics (GCBE) at Stanford. Dr. Ng is an applied health scientist whose work evaluates the real-world impact of emerging technologies on people and society. Her research has consistently shown that technological solutions alone are insufficient in addressing the shortcomings inherent in the biomedical research ecosystem.
Prior to Dr. Ng's appointment at GCBE, she was a Postdoctoral Scholar at the Stanford Division in Computation Medicine leading foundational work in AI ethics, governance, and responsible innovation. She will further her training in ELSI research at the intersection of generative biology, multisector research practices, and regulation. As generative AI continues to advance rapidly, she aims to embed ethics into the core of health AI development, operations, and decision-making. -
Andrew Thai Nguyen
Clinical Scholar, Medicine - Cardiovascular Medicine
Postdoctoral Scholar, Cardiovascular MedicineBioDr. Andrew Nguyen is a Cardiologist and a Clinical Scholar in the Department of Medicine, Division of Cardiovascular Medicine. He earned his medical degree from Harvard Medical School in the Harvard-MIT Health Sciences and Technology Program. He then completed his residency in Internal Medicine at Stanford University, followed by fellowship training in Cardiovascular Medicine also at Stanford University.
As a non-invasive cardiologist, Dr. Nguyen cares for patients undergoing cancer therapy as well as cancer survivors in the Stanford Health Care Cardio-Oncology Program. He provides evidenced-based cardiovascular care for patients throughout their cancer journey while managing and preventing treatment toxicities. Dr. Nguyen is a physician scientist who is mentored by Dr. Paul Cheng and Dr. Tom Quertermous. His research blends his clinical interest in cardio-oncology with basic science to understand the complex interplay between cancer angiogenesis and ischemic heart disease. He is a recipient of the AHA Postdoctoral Fellowship Award, ACC/Merck Research Fellowship Award, and NIH F32 Award. -
Humaira Noor
Postdoctoral Scholar, Biomedical Informatics
BioDr. Humaira Noor is a postdoctoral researcher in the Gevaert Lab with a PhD in glioma genomics from University of New South Wales, Australia. Her expertise spans biomarker discovery, with particular emphasis on prognostic and molecular determinants of glioma treatment-response, radiogenomic model development for early high-risk patient stratification, and the integration of multi-omics and biomedical imaging to advance precision oncology
-
Emmanuel Nsamba
Postdoctoral Scholar, Developmental Biology
BioHere is my google scholar
https://scholar.google.com/citations?user=RKnoiR8AAAAJ&hl=en -
Cynthia Nyongesa
Postdoctoral Scholar, Psychiatry
BioCynthia graduated from the University of California San Diego in 2026 with a Ph.D. in Computational Neurosciences. Her dissertation focused on multimodal digital biomarkers, using speech, virtual reality, and eye-tracking to detect Alzheimer's disease years before symptoms emerge. Growing up in Nairobi, Kenya, Cynthia developed an early passion for accessible healthcare, particularly for communities with limited access to advanced diagnostics. She is now a Postdoctoral Fellow in Dr. Ehsan Adeli's STAI Lab at Stanford, supported by the PRISM Baker Fellowship, where she is extending her work on passive biomarkers to gait, mobility, and neuroimaging.
-
Connor Galen O'Brien
Postdoctoral Medical Fellow, Cardiovascular Medicine
BioDr. O'Brien is a native of Menlo Park, CA. He attended medical school at Columbia University College of Physicians and Surgeons. At Columbia he was elected to both Alpha Omega Alpha and Gold Humanism Honors Societies. He completed an Internal Medicine residency as well as fellowship in Cardiovascular Medicine at Stanford University. In his third year of fellowship, he was selected Chief Cardiology Fellow.
He is currently a post-doctoral fellow performing regenerative medicine research, specifically studying the role of exosomes in treating cardiomyopathy. In addition to his basic science research, he is also involved in human clinical trials investigating the role of stem cells in treating various forms of cardiomyopathy. -
Cerag Oguztuzun
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
Biohttps://cerag.neurograph.net/
-
Luka Ojemaye
Postdoctoral Scholar, SCRDP/ Heart Disease Prevention
Current Research and Scholarly InterestsHis research advances health and performance through an interdisciplinary framework integrating clinical rehabilitation, biomechanics, and physical activity. His work examines prevention and care, physical activity interventions, and the psychosocial factors that influence health and performance outcomes.
-
Michelle Ozaki
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsResearch interests include tumor microenvironment interactions, stromal and tumor cell interactions, and how stromal cells impact metastasis.
-
Yellappa Palagani
Postdoctoral Scholar, Cardiothoracic Surgery
BioYellappa Palagani is currently a Postdoctoral Fellow in Cardiothoracic Surgery at Stanford University. In Dr Ma's lab, he is developing an MRI-compatible mock circulatory loop using cardiac phantoms to simulate complex congenital heart defects, an ex-vivo preservation system for pediatric heart transplantation, and an adjustable pulmonary artery band for managing congenital heart diseases. Before joining Stanford, he was a Postdoctoral Associate in Adult Cardiac Surgery at Yale University from April 2021 to March 2023, where he worked under the supervision of Pramod Bonde, MD, on left ventricular assist devices and smart inductive stents. In August 2020, he received his PhD in Electronics Engineering from Kyungpook National University, South Korea, under the supervision of Jun Rim Choi, PhD. During his doctoral program, he worked on wirelessly powered cardiac pacemakers and wearable cardiac arrhythmia indicators.